Questions,"number of pt treated with INF-free DAA  with public insurance (e.g. Medicaid, Medicare, other public insurance)",What is the number of female patients among all CHC patients,"number all CHC pt with public insurance (e.g. Medicaid, Medicare, other public insurance)","country, date of the publication",What is the name of the authors,"what is the start date, end date of the study ?"
Answers,"Based on the provided text, a total of 464 Medicaid members were treated with Direct-Acting Antivirals (DAAs) for Hepatitis C between January 2014 and June 2015. This information specifically pertains to Medicaid members, which is a form of public insurance.","The number of female patients among all CHC patients is 1,998.","Among the 3,412 Medicaid members with chronic HCV in the study, 13.6% (464 patients) received Direct-Acting Antivirals (DAAs).","The country of the publication is the United States, and the date of the publication is in 2015.","The authors of the publication are Shellie L. Keast, PharmD, PhD; Bethany Holderread, PharmD; Terry Cothran, DPh; and Grant H. Skrepnek, PhD from the University of Oklahoma College of Pharmacy, Oklahoma City.","The study's review period was from January 1, 2014, to June 30, 2015."
